Application Nr Approved Date Route Status External Links
NDA205266 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Odomzo (Sonidegib) Is Indicated For The Treatment Of Adult Patients With Locally Advanced Basal Cell Carcinoma (Bcc) That Has Recurred Following Surgery Or Radiation Therapy, Or Those Who Are Not Candidates For Surgery Or Radiation Therapy. Odomzo Is A Hedgehog Pathway Inhibitor Indicated For The Treatment Of Adult Patients With Locally Advanced Basal Cell Carcinoma (Bcc) That Has Recurred Following Surgery Or Radiation Therapy, Or Those Who Are Not Candidates For Surgery Or Radiation Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sonidegib Phosphate

Comments